Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Clinical Nuclear Medicine|November 8, 2016
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer PatientsChristina Bluemel, Stefanie Hahner, Britta Heinze, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 21, 2015
Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixaforKen Herrmann, Constantin Lapa, Hans-Juergen Wester, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2014
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patientsConstantin Lapa, Thomas Linsenmann, Camelia Maria Monoranu, et al.EJNMMI Research|May 16, 2015
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapyConstantin Lapa, Rudolf A Werner, Christina Bluemel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2016
68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 PatientsWolfgang Peter Fendler, Martin Barrio, Claudio Spick, et al.Molecular Imaging and Biology|January 22, 2008
Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trialSandra Pauls, Andreas K Buck, Gisela Halter, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 25, 2015
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanomaChristina Bluemel, Ken Herrmann, Francesco Giammarile, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.Endocrine|May 4, 2016
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomographyRudolf A Werner, Matthias Kroiss, Masatoyo Nakajo, et al.Clinical Nuclear Medicine|March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTChristina Bluemel, Markus Krebs, Bülent Polat, et al.Pageof 5